family / friend
Surprised by diagnosis, Mark learns to live with low-risk Myelodysplastic Syndrome
Mark had no symptoms prior to diagnosis. Even more surprising was the "watch and wait" treatment plan! Listen to this recently recorded episode where Mark describes living as an MDS survivor now.
Angela Smith, MD, MS
Smith, Angela
Associate Professor, Department of Pediatrics
Children’s Minnesota Hematology Oncology
Angela Smith joined the Department of Pediatrics in July 2008 in the Division of Hematology/Oncology/Blood and Marrow Transplantation and became Director of the Division Blood and Marrow Transplantation in 2019.
Online Profile:
Evan Shereck, MD, MEd
Shereck, Evan
Associate Professor of Pediatrics, Division of Hematology and Oncology
OHSU Hospital
Dr. Shereck specializes in bone marrow transplantation for children with cancer, blood disorders and immunodeficiencies. She conducts clinical trials as a part of the Primary Immune Deficiency Treatment Consortium (PIDTC) and the Pediatric Blood and Marrow Transplant Consortium (PBMTC).
Online Profile:
Jeffrey J. Pu, MD, PhD
Pu, Jeffrey J.
Associate Professor
SUNY Upstate Medical University
Bhumika Patel, MD
Patel, Bhumika
Prisma Health Cancer Institute - Eastside
Mrinal Patnaik, MD, MBBS
Patnaik, Mrinal
Associate Professor of Medicine
Mayo Clinic Minnesota
Online Profile:
Gabrielle Meyers, MD
Meyers, Gabrielle
Associate Professor of Medicine at the School of Medicine
OHSU Hospital
Dr. Meyers was born and raised in rural Northern California and traveled around the country during her medical training. She developed an interest in hematology and oncology during medical school, and pursued a fellowship in that field after her internal medicine residency.
Online Profile:
Gregory Abel, MD, MPH
Abel, Gregory
Dana-Farber Cancer Institute
Dr. Abel received his MD and MPH from Columbia University in 2000. He completed his postgraduate training in internal medicine at Massachusetts General Hospital and his hematology/oncology fellowship at Dana-Farber Cancer Institute. In 2007, he joined Dana-Farber and is a member of the Hematologic Malignancies staff, as well as the Center for Outcomes and Policy Research.
Online Profile:
Brian finds his way through low-risk, long-term MDS
Brian's surprise MDS diagnosis leads to an unsettling strategy: watch and wait! Listen to him describe how he makes the most from the long-term waiting with low-risk MDS in this conversation with AAMDSIF.